Could AI create a brave new world of pharma R&D?
Barely a week goes by without one big pharma or biotech announcing that it is using AI to develop new medicines. Richard Staines looks at the progress already made thanks to this potentially revolutionary technology, and how it could change the fortunes of a beleaguered pharma industry.
Artificial Intelligence (AI) has become the latest buzz word in drug R&D, and many of the world’s biggest pharma companies claim to be using it to drive forward the process of scientific discovery.
The concept is that using AI’s capabilities, the previously unpredictable process of drug development can become much more predictable, and as a result less expensive.
While it is still early days, AI in its many guises can be used at many points during drug research process.